Concord Drugs Limited (BOM:538965)
India
· Delayed Price · Currency is INR 76.91
+2.71 (3.65%)
At close: Mar 10, 2026
Concord Drugs Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,013 | 311 | 352 | 256 | 254 | 254 | Upgrade
|
| Market Cap Growth | 209.68% | -11.63% | 37.54% | 0.84% | -0.17% | 146.63% | Upgrade
|
| Enterprise Value | 1,201 | 501 | 521 | 428 | 362 | 351 | Upgrade
|
| Last Close Price | 76.91 | 31.08 | 35.17 | 27.45 | 29.00 | 29.05 | Upgrade
|
| PE Ratio | 169.19 | 92.45 | 74.47 | 25.95 | 15.91 | 7.74 | Upgrade
|
| PS Ratio | 1.98 | 0.69 | 0.78 | 0.49 | 0.43 | 0.49 | Upgrade
|
| PB Ratio | 2.94 | 0.91 | 1.04 | 0.81 | 0.89 | 0.95 | Upgrade
|
| P/TBV Ratio | 2.94 | 0.91 | 1.04 | 0.81 | 0.89 | 0.95 | Upgrade
|
| P/FCF Ratio | - | 22.37 | - | 31.71 | - | - | Upgrade
|
| P/OCF Ratio | - | 8.35 | 44.39 | 15.38 | 32.75 | 1567937.89 | Upgrade
|
| EV/Sales Ratio | 2.34 | 1.11 | 1.16 | 0.82 | 0.61 | 0.68 | Upgrade
|
| EV/EBITDA Ratio | 29.87 | 12.12 | 12.88 | 9.36 | 6.37 | 10.63 | Upgrade
|
| EV/EBIT Ratio | 44.75 | 18.54 | 20.93 | 14.52 | 9.24 | 18.11 | Upgrade
|
| EV/FCF Ratio | - | 36.08 | - | 53.05 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.56 | 0.56 | 0.52 | 0.54 | 0.58 | 0.49 | Upgrade
|
| Debt / EBITDA Ratio | 4.76 | 4.65 | 4.33 | 3.71 | 2.89 | 3.92 | Upgrade
|
| Debt / FCF Ratio | - | 13.85 | - | 21.04 | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.55 | 0.56 | 0.51 | 0.53 | 0.58 | 0.48 | Upgrade
|
| Net Debt / EBITDA Ratio | 4.67 | 4.60 | 4.29 | 3.69 | 2.88 | 3.91 | Upgrade
|
| Net Debt / FCF Ratio | - | 13.69 | -76.85 | 20.91 | -9.73 | -3.52 | Upgrade
|
| Asset Turnover | - | 0.73 | 0.77 | 0.91 | 1.11 | 0.95 | Upgrade
|
| Inventory Turnover | - | 1.48 | 1.57 | 2.22 | 2.90 | 3.07 | Upgrade
|
| Quick Ratio | - | 0.53 | 0.61 | 0.74 | 0.97 | 1.28 | Upgrade
|
| Current Ratio | - | 1.56 | 1.79 | 2.01 | 1.77 | 2.22 | Upgrade
|
| Return on Equity (ROE) | - | 0.99% | 1.44% | 3.28% | 5.78% | 13.06% | Upgrade
|
| Return on Assets (ROA) | - | 2.73% | 2.66% | 3.21% | 4.60% | 2.25% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.64% | 2.52% | 3.75% | 4.98% | 6.58% | 4.08% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 6.90% | 6.60% | 8.00% | 11.90% | 5.80% | Upgrade
|
| Earnings Yield | 0.56% | 1.08% | 1.34% | 3.85% | 6.29% | 12.92% | Upgrade
|
| FCF Yield | - | 4.47% | -0.64% | 3.15% | -6.63% | -14.46% | Upgrade
|
| Buyback Yield / Dilution | -25.47% | - | -7.35% | -6.53% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.